BG60533B2 - Заместени имидазолидини,метод за получаването ими приложението им като лекарствено средство и състави,които ги съдържат - Google Patents

Заместени имидазолидини,метод за получаването ими приложението им като лекарствено средство и състави,които ги съдържат Download PDF

Info

Publication number
BG60533B2
BG60533B2 BG98507A BG9850794A BG60533B2 BG 60533 B2 BG60533 B2 BG 60533B2 BG 98507 A BG98507 A BG 98507A BG 9850794 A BG9850794 A BG 9850794A BG 60533 B2 BG60533 B2 BG 60533B2
Authority
BG
Bulgaria
Prior art keywords
trifluoromethyl
nitrophenyl
dimethyl
compound
dimethylimidazoline
Prior art date
Application number
BG98507A
Other languages
Bulgarian (bg)
English (en)
Inventor
Claude Bonne
Pierre Girault
Jacques Perronnet
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of BG60533B2 publication Critical patent/BG60533B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
BG98507A 1975-10-29 1994-02-22 Заместени имидазолидини,метод за получаването ими приложението им като лекарствено средство и състави,които ги съдържат BG60533B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7533084A FR2329276A1 (fr) 1975-10-29 1975-10-29 Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant

Publications (1)

Publication Number Publication Date
BG60533B2 true BG60533B2 (bg) 1995-07-28

Family

ID=9161795

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98507A BG60533B2 (bg) 1975-10-29 1994-02-22 Заместени имидазолидини,метод за получаването ими приложението им като лекарствено средство и състави,които ги съдържат

Country Status (18)

Country Link
US (1) US4097578A (fr)
JP (1) JPS6011701B2 (fr)
AU (1) AU500542B2 (fr)
BE (1) BE847742A (fr)
BG (1) BG60533B2 (fr)
CA (1) CA1086751A (fr)
CH (1) CH599164A5 (fr)
DE (1) DE2649925C2 (fr)
DK (1) DK152125C (fr)
ES (1) ES452746A1 (fr)
FR (1) FR2329276A1 (fr)
GB (1) GB1518444A (fr)
GE (1) GEP19970948B (fr)
IE (1) IE43875B1 (fr)
LU (2) LU76085A1 (fr)
NL (2) NL187102C (fr)
SE (1) SE430502B (fr)
SU (1) SU596165A3 (fr)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1138334A (fr) * 1977-10-28 1982-12-28 Karl Bernauer Preparations pharmaceutiques contenant certains derives de l'uree
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
FI801184A (fi) * 1979-04-24 1980-10-25 Hoffmann La Roche Foerfarande foer framstaellning av imidazolidinderivat
US4666885A (en) * 1985-02-08 1987-05-19 Fernand Labrie Combination therapy for treatment of female breast cancer
JPH0680016B2 (ja) * 1984-08-02 1994-10-12 ラブリ−，フエルナンド ホルモン依存性がんの併用治療のための医薬組成物
US4775660A (en) * 1984-08-02 1988-10-04 Fernand Labrie Treatment of breast cancer by combination therapy
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
US5084472A (en) * 1986-11-04 1992-01-28 Roussel Application of 1-(3'-trifluoromethyl-4'-nitrophenyl)-4,4'-dimethylimidazoline 2,5-dione in the treatment of hormone-dependent cancers other than that of the prostate
IT1214735B (it) * 1986-11-04 1990-01-18 Roussel Maestretti Spa Impiego di 1-(3'-trifluorometil 4'nitrofenil) 4,4-dimetilimidazolin2,5-dione per il trattamento di cancri ormonodipendenti diverso da quello della prostata
FR2619381B1 (fr) * 1987-08-13 1989-12-08 Roussel Uclaf Nouvelles imidazolidines substituees par un radical hydroxymethyle et un radical phenyl substitue, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant et un intermediaire pour leur preparation
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
FR2656302B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveau procede de preparation de l'anandron et derives de l'anandron.
FR2693461B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
FR2671348B1 (fr) * 1991-01-09 1993-03-26 Roussel Uclaf Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
US6002016A (en) * 1991-12-20 1999-12-14 Rhone-Poulenc Agrochimie Fungicidal 2-imidazolin-5-ones and 2-imidazoline-5-thiones
FR2706456B1 (fr) 1993-06-18 1996-06-28 Rhone Poulenc Agrochimie Dérivés optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
FR2685328B1 (fr) * 1991-12-20 1995-12-01 Rhone Poulenc Agrochimie Derives de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
FR2694290B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
US6008370A (en) * 1992-11-25 1999-12-28 Rhone-Poulenc Agrochimie Fungicidal-2-alkoxy/haloalkoxy-1-(mono- or disubstituted)amino-4,4-disubstituted-2-imidazolin-5-ones
FR2724169B1 (fr) * 1994-09-06 1997-01-03 Roussel Uclaf Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2715402B1 (fr) * 1994-01-05 1996-10-04 Roussel Uclaf Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
TW521073B (en) * 1994-01-05 2003-02-21 Hoechst Marion Roussel Inc New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
FR2725206B1 (fr) * 1994-09-29 1996-12-06 Roussel Uclaf Nouvelles imidazolidines substituees par un heterocycle, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
US5656651A (en) * 1995-06-16 1997-08-12 Biophysica Inc. Androgenic directed compositions
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
CN1454083A (zh) * 2000-06-28 2003-11-05 布里斯托尔-迈尔斯斯奎布公司 选择性雄激素受体调节剂及其鉴定、设计和应用的方法
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7001911B2 (en) 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
EP1854798A3 (fr) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Composés de succinimide hétérocyclique fondu et leurs analogies, modulateurs de la fonction de récepteur d'hormone nucléaire
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
AU2002322493A1 (en) * 2001-07-10 2003-01-29 Ams Research Corporation Surgical kit for treating prostate tissue
PL206962B1 (pl) * 2001-12-19 2010-10-29 Bristol Myers Squibb Co Związek heterocykliczny o budowie skondensowanej
FR2850652B1 (fr) * 2003-01-31 2008-05-30 Aventis Pharma Sa Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
US7354933B2 (en) * 2003-01-31 2008-04-08 Aventis Pharma Sa Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
CA2536349A1 (fr) * 2003-08-22 2005-03-03 Ligand Pharmaceuticals Incorporated Derives de 6-cycloamino-2-quinolinone utilises comme composes modulateurs des recepteurs d'androgenes
RU2422450C2 (ru) 2003-11-19 2011-06-27 Метабазис Терапеутикс, Инк. Новые фосфорсодержащие тиромиметики
EP2299266A1 (fr) * 2003-12-19 2011-03-23 The Regents of the University of California Procédés et matériels pour évaluer les thérapies du cancer de la prostate
US7718684B2 (en) * 2004-02-24 2010-05-18 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US8519158B2 (en) 2004-03-12 2013-08-27 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
WO2006031715A2 (fr) * 2004-09-10 2006-03-23 Janssen Pharmaceutica N.V. Derives d'imidazolidine-2-one en tant que modulateurs selectifs du recepteur androgenique
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
ME01992B (fr) 2005-05-13 2012-10-30 Univ California Composes diarylhydantoines
WO2006138347A2 (fr) * 2005-06-17 2006-12-28 Ligand Pharmaceuticals Incorporated Composes modulateurs du recepteur des androgenes et procedes associes
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
FR2896503B1 (fr) * 2006-01-23 2012-07-13 Aventis Pharma Sa Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
PL3100727T3 (pl) 2006-03-27 2019-01-31 The Regents Of The University Of California Modulator receptora androgenowego do leczenia raka gruczołu krokowego i chorób związanych z receptorem androgenowym
KR20160027254A (ko) 2006-03-29 2016-03-09 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴티오히단토인 화합물
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
US7882841B2 (en) 2007-01-02 2011-02-08 Procept Corporation Minimally invasive methods and devices for the treatment of prostate diseases
US9232959B2 (en) 2007-01-02 2016-01-12 Aquabeam, Llc Multi fluid tissue resection methods and devices
US20080245375A1 (en) * 2007-04-05 2008-10-09 Medtronic Vascular, Inc. Benign Prostatic Hyperplasia Treatments
CA2703635C (fr) 2007-10-26 2017-06-27 Michael E. Jung Composes de diarylhydantoine en tant que modulateurs des recepteurs androgenes
JP5506702B2 (ja) 2008-03-06 2014-05-28 アクアビーム エルエルシー 流体流れ内を伝達される光学エネルギーによる組織切除および焼灼
WO2010093601A1 (fr) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Nouveaux thyromimetiques contenant de l'acide sulfonique et methodes d'utilisation associees
US9848904B2 (en) 2009-03-06 2017-12-26 Procept Biorobotics Corporation Tissue resection and treatment with shedding pulses
FR2944524B1 (fr) 2009-04-17 2012-11-30 Ipsen Pharma Sas Derives d'imidazolidine-2,4-dione et leur utilisation comme medicament
CA2787083C (fr) 2010-02-16 2018-05-22 Aragon Pharmaceuticals, Inc. Modulateurs du recepteur des androgenes et leurs utilisations
ES2634669T3 (es) 2011-02-08 2017-09-28 Halozyme, Inc. Composición y formulación lipídica de una enzima de degradación de hialuronano y uso de la misma para el tratamiento de la hiperplasia benigna de próstata
EP2819599B1 (fr) 2012-02-29 2018-05-23 Procept Biorobotics Corporation Résection et traitement de tissu guidés par image automatisée
CN109908114A (zh) 2012-09-26 2019-06-21 阿拉贡药品公司 用于治疗非转移性去势抵抗性前列腺癌的抗雄激素
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
CN105431096B (zh) 2013-02-14 2018-07-31 普罗赛普特生物机器人公司 液体消融液体束眼外科手术的方法和装置
EP3327144B1 (fr) 2013-02-25 2020-03-25 Novartis AG Nouvelle mutation du récepteur d'androgène
CN105764436B (zh) 2013-09-06 2019-04-26 普罗赛普特生物机器人公司 利用致脱脉冲的用于消融组织的装置
CN106572864B (zh) 2014-06-30 2020-06-09 普罗赛普特生物机器人公司 流体射流组织切除和寒凝装置
JP2017532095A (ja) 2014-09-05 2017-11-02 プロセプト バイオロボティクス コーポレイション 標的器官画像の処理マッピングと一体化された医師制御組織切除
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
EP3500310A1 (fr) 2016-08-20 2019-06-26 FTF Pharma Private Limited Composition pharmaceutique comprenant un inhibiteur du récepteur des androgènes
CN107216290B (zh) * 2017-06-12 2021-03-16 陕西科技大学 一种3-丁基-5,5-二甲基海因咪唑季铵盐及其制备方法
AU2018351714A1 (en) 2017-10-16 2020-04-30 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB997037A (en) * 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
JPS4920973B1 (fr) * 1970-05-28 1974-05-29
JPS5136332B1 (fr) * 1970-12-09 1976-10-07
IL45459A (en) * 1973-09-03 1978-01-31 Ciba Geigy Ag 1-(dichlorofluoromethylthio)-3-phenyl-imidazolidine-2,4-dione derivatives their preparation and their use as bactericides and fungicides

Also Published As

Publication number Publication date
SE430502B (sv) 1983-11-21
NL187102B (nl) 1991-01-02
NL930079I2 (nl) 1993-10-01
DK487476A (da) 1977-04-30
DE2649925A1 (de) 1977-05-12
DE2649925C2 (de) 1986-08-28
NL930079I1 (nl) 1993-09-16
GB1518444A (en) 1978-07-19
IE43875L (en) 1977-04-29
LU88282I2 (fr) 1994-05-04
CH599164A5 (fr) 1978-05-12
BE847742A (fr) 1977-04-28
SU596165A3 (ru) 1978-02-28
LU76085A1 (fr) 1977-05-31
FR2329276A1 (fr) 1977-05-27
JPS5257176A (en) 1977-05-11
IE43875B1 (en) 1981-06-17
NL7611576A (nl) 1977-05-03
AU1909576A (en) 1978-05-04
NL187102C (nl) 1991-06-03
SE7610859L (sv) 1977-04-30
FR2329276B1 (fr) 1979-09-14
CA1086751A (fr) 1980-09-30
DK152125C (da) 1988-06-20
GEP19970948B (en) 1997-04-18
JPS6011701B2 (ja) 1985-03-27
DK152125B (da) 1988-02-01
ES452746A1 (es) 1977-10-01
AU500542B2 (en) 1979-05-24
US4097578A (en) 1978-06-27

Similar Documents

Publication Publication Date Title
BG60533B2 (bg) Заместени имидазолидини,метод за получаването ими приложението им като лекарствено средство и състави,които ги съдържат
KR960016119B1 (ko) 히드록시메틸기 및 치환된 페닐기에 의해 치환된 신규의 이미다졸리딘, 이들의 제조방법, 의약으로서 이들의 용도, 이들을 함유하는 제약조성물 및 이들의 제조를 위한 중간체
ES2280555T3 (es) Derivados de n-fenilpirrol guanidina como ligandos del receptor de melanocortina.
EP0578516A1 (fr) Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
CA2648139A1 (fr) Composes de diarylthiohydantoine et leur utilisation dans le traitement de troubles d'hyperproliferation
Zinnes et al. 1, 2-Benzothiazines. III. The Preparation of 2H-1, 2-Benzothiazin-4 (3H)-one 1, 1-Dioxide by the Acid-Catalyzed Deacetylation of β-Diketone
JPS63502180A (ja) アミノグリコシド　ステロイド、それらの製造方法、それらの使用法及びそれらを含有する治療用組成物
US3993781A (en) 1,6-Dibromo-1,6-dideoxy-dulcitol and pharmaceutical compositions containing same
US3740401A (en) 2-(n-cycloalkyl-phenylamino)-2-imidazolines-(2) and salts thereof
DE1298993B (de) 3-Oxo-8ª‡-17ª‰-hydroxy-17ª‡-aethinyl-oestr-5(10)-en in seiner racemischen und linksdrehenden Form und Verfahren zur Herstellung dieser Verbindungen
US4108993A (en) 3-oxo-5,6-dihydro-1,2,4-oxadiazines useful as antiandrogenic agents
CA1110229A (fr) Obtention de derives de 3-amino-17a-aza-d- homoandrostane; produits pharmaceutiques qui en contiennent
CH630909A5 (en) New 3,5-disubstituted-1H-1,2,4-triazoles
US3420842A (en) Process for the preparation of 2-nitroimidazoles
AT395587B (de) Herstellung und verwendung neuer azolderivate, und sie enthaltende pharmazeutische praeparate
RU2448089C1 (ru) 4-МЕТИЛАНИЛИД-N-н-ПРОПИЛПИРРОЛИДИН-2-КАРБОНОВОЙ КИСЛОТЫ БОРАТ, ПРОЯВЛЯЮЩИЙ АНТИГЕЛЬМИНТНУЮ АКТИВНОСТЬ
US4000291A (en) Oxazolidine, 2-4 diones useful as antiandrogenics
HU191685B (en) Process for preparung spiro-imidazolidine-indoline derivatives
CH632763A5 (en) Triazolothiadiazine derivatives and processes for preparing them
Takeda et al. The stereochemistry of dihydrolycorine.
JPH11505240A (ja) 減量用薬剤
US3981997A (en) Analgesic compositions comprising 1H- or respectively 2H-indazolone-3 (β-morpholino-alkoxy) compounds
FI84834C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara steroidderivat av androstanserien.
IE45480B1 (en) N-2,6-dichlorophenyl-2-aminopyrimidine and therapeutic compositions containing it
US3334013A (en) Substituted 17beta-androst-4-en-3-one and 19-norandrost-4-en-3-one and method of preparing the same